Center of Disease Control and Prevention of Anhui Province, Hefei, 230009, China.
Engineering Research Center of Bio-process, MOE, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, PR China; Department of Nutrition and Food Hygiene, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Biosens Bioelectron. 2022 Feb 1;197:113771. doi: 10.1016/j.bios.2021.113771. Epub 2021 Nov 6.
Due to the similar clinical symptoms of influenza (Flu) and coronavirus disease 2019 (COVID-19), there is a looming infection threat of concurrent Flu viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this work, we introduce a customized isothermal amplification integrated lateral flow strip (LFS) that is capable performing duplex reverse transcription-recombinase polymerase amplification (RT-RPA) and colorimetric LFS in a sequential manner. With customized amplification primer sets targeted to SARS-CoV-2 (opening reading frame 1a/b and nucleoprotein genes) and Flu viruses (Flu A and Flu B), the platform allows the rapid and simultaneous visual screening of SARS-CoV-2 and Flu viruses (Flu A and Flu B) without cross reactivity, false positives, and false negatives. Moreover, it maximally eases the detection, reduces the detection time (1 h), and improves the assay performance to detect as low as 10 copies of the viral RNA. Its clinical application is powerfully demonstrated with 100% accuracy for evaluating 15 SARS-CoV-2-positive clinical samples, 10 Flu viruses-positive clinical samples, and 5 negative clinical samples, which were pre-confirmed by standard qRT-PCR. We envision this portable device can meet the increasing need of online monitoring the serious infectious diseases that substantially affects health care systems worldwide.
由于流感 (Flu) 和 2019 年冠状病毒病 (COVID-19) 的临床症状相似,因此存在 Flu 病毒和严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 同时感染的潜在威胁。在这项工作中,我们引入了一种定制的等温扩增集成侧流条 (LFS),它能够顺序进行双管反转录-重组酶聚合酶扩增 (RT-RPA) 和比色 LFS。该平台针对 SARS-CoV-2(开放阅读框 1a/b 和核蛋白基因)和 Flu 病毒(Flu A 和 Flu B)使用定制的扩增引物组,允许快速且同时对 SARS-CoV-2 和 Flu 病毒(Flu A 和 Flu B)进行目视筛查,而不会发生交叉反应、假阳性和假阴性。此外,它最大限度地简化了检测,缩短了检测时间(1 小时),并提高了检测低至 10 个拷贝病毒 RNA 的分析性能。通过对 100%经标准 qRT-PCR 预确认的 15 个 SARS-CoV-2 阳性临床样本、10 个 Flu 病毒阳性临床样本和 5 个阴性临床样本的评估,有力地证明了该临床应用。我们设想这种便携式设备可以满足全球医疗保健系统受到严重影响的严重传染病在线监测需求的不断增长。